Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.21 (423.57% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetActions
5/21/2015Cantor FitzgeraldInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015HC WainrightInitiated CoverageBuy$1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Chardan CapitalLower Price TargetBuy$2.25 -> $1.55View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Ascendiant Capital MarketsInitiated CoverageBuy$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Chardan CapitalInitiated CoverageBuy$2.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Maxim GroupSet Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Maxim GroupInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2014Maxim GroupBoost Price TargetBuy$2.50 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2014Chardan CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Maxim GroupReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Edison Investment ResearchNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)